
Sunshine Biopharma acquires Nora Pharma for C$30M
111.14KUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US8677814035
CUSIP
867781403
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
11.52
Dividend Share
-
Dividend Yield
-
Earnings Share
-189
Wall Street Target Price
56.00
EPS Estimate Current Year
-1.95
EPS Estimate Next Year
-0.40
EPS Estimate Current Quarter
-1.2
EPS Estimate Next Quarter
-0.2
Most Recent Quarter
-
Revenue TTM
35,346,772
Gross Profit TTM
10,710,057
EBITDA
-4,848,974
Profit Margin
-16.50%
Return On Assets TTM
-9.91%
Return On Equity TTM
-21.92%
Revenue Per Share TTM
49.666
Qtly Revenue Growth YOY
-1.60%
Diluted Eps TTM
-189
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0.0031
Price Book MRQ
0.1277
Enterprise Value Revenue
0
Enterprise Value EBITDA
-7
239.95
3.94%99.09
1.98%40.44
1.46%32.14
0.19%161.82
0.04%12.25
0.00%41.22
0.00%10.08
-1.17%20.28
-0.76%46.10
-0.43%